Evidence map›Paper›PMID 33553589›Full record

ArticleEndoscopy international open2021

EUS-guided placement of fiducial markers for stereotactic body radiation therapy in pancreatic cancer: feasibility, security and a new quality score.

Mariana Figueiredo, Christelle Bouchart, Luigi Moretti, Laura Mans, Jean-Luc Engelholm, Maria-Antonietta Bali, Jean-Luc Van Laethem, Pierre Eisendrath

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Endoscopy international open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05083247 (Preoperative Treatment With mFOLFIRINOX), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05083247 phase2recruitingnot on this mapstarted 2023, after this paper: background citation

Preoperative Treatment With mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose Stereotactic Body Radiation Therapy (iHD-SBRT) for Borderline Resectable Pancreatic Adenocarcinoma: a Randomised Phase II Study (STEREOPAC)

TypeinterventionalSponsorErasme University HospitalRan2023 to 2030Enrolled256ConditionsPancreatic Neoplasm, Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic AdenocarcinomaArmsmFOLFIRINOX or Gemcitabine nab-paclitaxel, Isotoxic High-Dose (iHD)-SBRT, Surgery
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mariana FigueiredoDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme University Hospital, Université Libre de Bruxelles, Belgium.
Christelle BouchartDepartment of Radiation-Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Belgium.
Luigi MorettiDepartment of Radiation-Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Belgium.
Laura MansDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme University Hospital, Université Libre de Bruxelles, Belgium.
Jean-Luc EngelholmDepartment of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Belgium.
Maria-Antonietta BaliDepartment of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Belgium.
Jean-Luc Van LaethemDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme University Hospital, Université Libre de Bruxelles, Belgium.
Pierre EisendrathDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme University Hospital, Université Libre de Bruxelles, Belgium.
Université Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33553589
PMCPMC7857973
OpenAlexW3127833022

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.